CXCL8 and myelodysplastic syndrome: In particular, TLR2 is overexpressed in the neoplastic CD34+ hematopoietic stem and progenitor cells characteristic of the myelodysplastic syndromes (MDS), and its activation induces the production of IL-8 and inhibits their erythroid differentiation [44].